News Teva charged in US price-fixing investigation The US Department of Justice has charged Teva with conspiring with other pharma companies to fix prices for generic drugs.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
